Foust Hollie K 4/A

What Happened

• Hollie K. Foust, General Counsel and Corporate Secretary of CONMED Corporation, was granted 18,563 restricted stock units (RSUs) on 2026-03-02. The award is reported as a derivative acquisition (code A) at an acquisition price of $0.00 (i.e., an equity award rather than an open-market purchase or sale). This Form 4/A amends an earlier filing to correct the grant amount — a special award of 7,644 RSUs was added to the originally reported 10,919 RSUs for a total of 18,563.

Key Details

• Transaction date: 2026-03-02; reported on amended Form 4 filed 2026-03-18 (filing was late relative to the 2-business-day Form 4 deadline).
• Price: $0.00 per RSU (award), total reported acquisition value listed as $0 (reflects grant, not cash paid).
• Vesting: RSUs are subject to the 2025 Long‑Term Incentive Plan and generally vest over three years — ~33% after year 1, 33% after year 2, and 34% after year 3 (per footnote).
• Amended filing note: Form 4/A corrects the RSU amount — added 7,644 RSUs to the originally reported 10,919.
• Shares owned after transaction: Not specified in the provided filing data.

Context

• RSUs are a form of compensation that convert into shares if and when they vest; they do not represent an immediate market purchase or sale. Because this is an award, it’s a compensation event rather than a direct trading signal. The late/amended filing corrects the reported grant size but does not change the nature of the award.